X-70927333-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_032803.6(SLC7A3):āc.1235T>Cā(p.Ile412Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,209,702 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., 1 hem., cov: 22)
Exomes š: 0.000018 ( 0 hom. 3 hem. )
Consequence
SLC7A3
NM_032803.6 missense
NM_032803.6 missense
Scores
8
7
2
Clinical Significance
Conservation
PhyloP100: 9.17
Genes affected
SLC7A3 (HGNC:11061): (solute carrier family 7 member 3) This gene encodes a member of the solute carrier family 7. The encoded protein is a sodium-independent cationic amino acid transporter. Alternate splicing results in multiple transcripts that encoded the same protein.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.918
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A3 | NM_032803.6 | c.1235T>C | p.Ile412Thr | missense_variant | 8/12 | ENST00000374299.8 | NP_116192.4 | |
SLC7A3 | NM_001048164.3 | c.1235T>C | p.Ile412Thr | missense_variant | 8/12 | NP_001041629.1 | ||
SLC7A3 | XM_047442598.1 | c.1235T>C | p.Ile412Thr | missense_variant | 7/11 | XP_047298554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC7A3 | ENST00000374299.8 | c.1235T>C | p.Ile412Thr | missense_variant | 8/12 | 1 | NM_032803.6 | ENSP00000363417.3 | ||
SLC7A3 | ENST00000298085.4 | c.1235T>C | p.Ile412Thr | missense_variant | 8/12 | 2 | ENSP00000298085.4 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 111761Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33917
GnomAD3 genomes
AF:
AC:
3
AN:
111761
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33917
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 182537Hom.: 0 AF XY: 0.0000298 AC XY: 2AN XY: 67005
GnomAD3 exomes
AF:
AC:
2
AN:
182537
Hom.:
AF XY:
AC XY:
2
AN XY:
67005
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000182 AC: 20AN: 1097941Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 3AN XY: 363299
GnomAD4 exome
AF:
AC:
20
AN:
1097941
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
363299
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000268 AC: 3AN: 111761Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33917
GnomAD4 genome
AF:
AC:
3
AN:
111761
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33917
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.1235T>C (p.I412T) alteration is located in exon 8 (coding exon 7) of the SLC7A3 gene. This alteration results from a T to C substitution at nucleotide position 1235, causing the isoleucine (I) at amino acid position 412 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at